Short report
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
Diagnostic Pathology 2011, 6:91 doi:10.1186/1746-1596-6-91
No comments have yet been made on this article.
Short report
